Literature DB >> 28415928

Incidence and risk factors for rectal pain after laparoscopic rectal cancer surgery.

Jin Young Lee1, Hee Cheol Kim2, Jung Wook Huh2, Woo Seog Sim1, Hyun Young Lim1, Eun Kyung Lee1, Hui Gyeong Park1, Yu Jeong Bang1.   

Abstract

Objective This study was performed to investigate the incidence of and potential risk factors for rectal pain after laparoscopic rectal cancer surgery. Methods We retrospectively analyzed data from 300 patients who underwent laparoscopic rectal cancer surgery. We assessed the presence of rectal pain and categorized patients into Group N (no rectal pain) or Group P (rectal pain). Results In total, 288 patients were included. Of these patients, 39 (13.5%) reported rectal pain and 14 (4.9%) had rectal pain that persisted for >3 months. Univariate analysis revealed that patients in Group P had more preoperative chemoradiotherapy, more ileostomies, longer operation times, more anastomotic margins of <2 cm from the anal verge, more anastomotic leakage, and longer hospital stays. Multivariate analysis identified an anastomotic margin of <2 cm from the anal verge and a long operation time as risk factors. The presence of diabetes mellitus was a negative predictor of rectal pain. Conclusions In this study, the incidence of rectal pain after laparoscopic rectal cancer surgery was 13.5%. An anastomotic margin of <2 cm from the anal verge and a long operation time were risk factors for rectal pain. The presence of diabetes mellitus was a negative predictor of rectal pain. Thus, the possibility of postoperative rectal pain should be discussed preoperatively with patients with these risk factors.

Entities:  

Keywords:  Anastomosis; laparoscopic surgery; rectal cancer; rectal pain

Mesh:

Year:  2017        PMID: 28415928      PMCID: PMC5536646          DOI: 10.1177/0300060517693421

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


Introduction

Despite rapid advancement in surgical techniques, laparoscopic rectal cancer surgery is still associated with a higher rate of complications than other laparoscopic colectomies.[1] The increased rate of complications is likely due to the difficult anatomic position of this surgery; the pelvis is narrow, resulting in a high risk of damage to the autonomic and/or somatic pelvic nerve plexus.[1-4] Common postoperative complications include anastomotic leakage, urinary and sexual dysfunction, perirectal abscess, prolonged ileus, rectovaginal fistula, and wound infection or dehiscence.[2,5] Acute postoperative pain is also an expected outcome. In patients who have undergone abdominal surgery, the pain manifests as a deep visceral pain inside the abdomen and/or parietal pain in the abdominal wall.[6] The estimated risk of chronic postsurgical pain is about 17% for laparoscopic colorectal surgery, depending on the indication for the surgery.[6,7] Intraoperative nerve damage and/or perioperative chemoradiotherapy (CRT) may also contribute to persistent postoperative pain.[8,9] However, some patients experience rectal pain for unclear reasons. Such pain can negatively affect the patients’ overall life quality and may be extremely costly.[3] Follmar et al.[10] suggested that a neural origin should be considered in the differential diagnosis of rectal pain if the onset of pain is related to previous surgery of the anus or rectum. The aim of this study was to determine the incidence of and risk factors for rectal pain after laparoscopic rectal cancer surgery.

Patients & Methods

Patients

This study was approved by our departmental ethics committee (2014-12-067) and registered with the Clinical Research Information Service (http://cris.cdc.go.kr, ref: KCT0001359). We retrospectively reviewed the electronic medical records of 300 patients who underwent elective laparoscopic rectal surgery from 2013 to 2014 in a single center. The patients ranged in age from 25 to 87 years. All patients had tumors located within 15 cm of the anal verge and underwent laparoscopic low anterior resection or anterior resection. The exclusion criteria were emergency surgery, a history of abdominal surgery, recurrent rectal lesions, metastatic rectal lesions, conversion to open laparotomy, and a lack of follow-up data.

Interventions

All surgeries were performed by one of six specialized colorectal surgeons who followed similar techniques, and tumor-specific mesorectal excision according to the tumor location was adopted as the standard surgical technique for rectal cancer. A double-stapling technique was applied for transanal anastomosis. Ileostomy for protection of low rectal anastomosis was performed at the surgeon’s discretion. All patients underwent general anesthesia and postoperative pain control with a patient-controlled analgesia device. The patient-controlled analgesia regimen involved fentanyl (1500 µg) and normal saline in a total volume of 100 ml. If postoperative analgesia was felt to be inadequate at any time, intravenous fentanyl, hydromorphone, or pethidine was supplied. Opioid consumption was recorded by conversion to fentanyl units throughout the operation and then again at 1 h, 1 day, 3 days, and 5 days postoperatively. Patient demographics, preoperative CRT, type of surgical resection, operation time, pathological stage, maximum tumor size, anastomotic margin from the anal verge, performance of ileostomy, postoperative complications, and length of hospital stay were analyzed. Postoperative abdominal pain was defined as pain that was located inside the abdomen and/or abdominal wall. Postoperative rectal pain was defined as pain that was located around the perineum with/without radiation to the lower extremities and that was not a continuation of preoperative pain. The pain included either somatic nociceptive or neuropathic characteristics (burning, shooting, or lancinating pain) or both. In the postoperative period, independent nurses evaluated abdominal and rectal pain using a numeric rating scale (0 = no pain, 10 =worst pain imaginable) at 1 h, 1 day, 3 days, 5 days, 1 month, 3 months, 6 months, and 12 months postoperatively. Chronic pain was defined as pain that persisted for at least 3 months postoperatively after exclusion of other causes of pain such as wound infection and/or malignancy.

Statistical analysis

All data were analyzed using SAS 9.4 (SAS Institute, Cary, NC, USA). Data are expressed as mean ± SD or frequency and proportion, as appropriate. Intergroup differences were assessed using Fisher’s exact test and the Mann–Whitney U test. Variables measured at different time points were compared using repeated-measures analysis of variance, with Bonferroni post hoc correction performed when appropriate. The potential risk factors for postoperative rectal pain were examined by univariate and multivariate analyses. A P value of <0.05 was considered to indicate statistical significance.

Results

In total, 300 patients were enrolled in this study; however, 12 met the exclusion criteria (2 patients were diagnosed with distant metastasis, 5 underwent open laparotomy, and 5 were lost to follow-up). Thus, 288 patients were included in the final analysis. Rectal pain was evaluated from the first 1 h postoperatively (Table 1). The demographic data and surgical characteristics are summarized in Table 2. Patients who experienced rectal pain at least once during the study period comprised Group P (n = 39). Patients without rectal pain comprised Group N (n = 249) (Table 2).
Table 1.

Rectal pain onset (n = 39).

Postoperative time point
1 h5 (12.8)
1 d3 (7.7)
3 d11 (28.2)
5 d8 (20.5)
1 mo6 (15.4)
3 mo3 (7.7)
6 mo3 (7.7)
12 mo0 (0.0)

All data are presented as n (%) patients.

Table 2.

Potential predictive factors for rectal pain.

All patients (n = 288)Group N (n = 249)Group P (n = 39)Univariate
Multivariate
95% CIP value95% CIP valueOR
Age, years60.7 ± 11.161.0 ± 11.158.3 ± 11.00.949–1.0080.148
 < 60125 (43.4)104 (41.8)21 (53.9)
 ≥60163 (56.6)145 (58.2)18 (46.2)
Sex, M/F177/111153/9624/150.502–2.0090.991
Height, cm162.1 ± 8.6161.9 ± 8.5163.5 ± 9.60.982–1.0650.478
Weight, kg60.7 ± 10.560.5 ± 10.561.7 ± 10.50.979–1.0440.497
BMI, kg/m223.0 ± 3.023.0 ± 3.023.0 ± 3.20.903–1.1280.877
 <25218 (75.7)187 (75.1)31 (79.5)0.553
 ≥2570 (24.3)62 (24.9)8 (20.5)
Charlson comorbidity index2.9 ± 1.52.9 ± 1.53.0 ± 1.60.863–1.3240.545
Presence of diabetes mellitus46 (16.0)44 (17.7)2 (5.1)0.0641.107–28.9800.0375.663
Preoperative CRT63 (21.9)46 (18.5)17 (43.6)*1.678–6.931<0.0010.431–3.1110.7711.158
Pathological stage
 I104 (36.1)88 (35.3)16 (41.0)0.123–9.7810.450
 II54 (18.8)48 (19.4)6 (15.4)0.077–7.338
 III104 (36.1)93 (37.5)11 (28.2)0.078–6.452
 IV25 (8.7)19 (7.7)6 (15.4)0.189–19.039
Preoperative pain (NRS)0.6 ± 1.80.2 ± 1.10.3 ± 1.20.830
Operation time, min177.0 ± 61.3168.6 ± 55.1230.4 ± 72.1*1.008–1.018<0.0011.006–1.018<0.0011.012
Ileostomy61 (24.5)45 (18.6)16 (41.0)*1.489–6.2290.001
Maximum tumor size of >4 cm92 (36.9)81 (32.7)11 (28.2)0.384–1.7080.580
Anastomotic margin of ≤2 cm from anal verge39 (15.7)23 (9.2)16 (41.0)*3.155–14.683<0.0012.475–13.542<0.0015.790
Length of hospital stay, days7.7 ± 5.47.4 ± 4.310.1 ± 9.7*1.013–1.1170.0130.966–1.1090.3241.035
Anastomotic leakage13 (4.5)8 (3.2)5 (12.8)*1.370–14.3260.0130.454–12.2800.3062.362

All data are presented as mean ± SD or n (%) patients. M/F: male/female; BMI: body mass index; CRT: chemoradiotherapy; NRS: numeric rating scale; CI: confidence interval; OR: odds ratio, Group N: patients without postoperative rectal pain; Group P: patients with postoperative rectal pain. *P < 0.05 compared with Group N.

Rectal pain onset (n = 39). All data are presented as n (%) patients. Potential predictive factors for rectal pain. All data are presented as mean ± SD or n (%) patients. M/F: male/female; BMI: body mass index; CRT: chemoradiotherapy; NRS: numeric rating scale; CI: confidence interval; OR: odds ratio, Group N: patients without postoperative rectal pain; Group P: patients with postoperative rectal pain. *P < 0.05 compared with Group N.

Univariate analysis

Age, sex, height, weight, body mass index, Charlson comorbidity index, pathological stage, and mean tumor size did not differ significantly between the two groups. Preoperative CRT was more frequently performed in Group P than Group N (P < 0.001). Moreover, Group P had longer operation times (P < 0.001), more ileostomies (P = 0.001), more anastomotic margins of < 2 cm from the anal verge (P < 0.001), longer hospital stays (P =0.013), and more anastomotic leakage (P = 0.013) than did Group N (Table 2).

Multivariate analysis

Factors with a P value of < 0.1 in the univariate analysis, including the presence of diabetes mellitus, performance of preoperative CRT, a long operation time, an anastomotic margin of <2 cm from the anal verge, and anastomotic leakage, were entered into a multivariate model. Multivariate stepwise logistic regression analysis revealed that an anastomosis margin of <2 cm from the anal verge (P < 0.001, OR = 5.790, CI =2.475–13.542) and a long operation time (P < 0.001, OR = 1.012, CI = 1.006–1.018) were significantly associated with rectal pain (Table 2). The presence of diabetes mellitus (P = 0.037, OR = 5.663, CI = 1.007–28.980) was a negative predictor of rectal pain (Table 2). Among these findings, an anastomotic margin of <2 cm from the anal verge showed the highest odds ratio for predicting rectal pain.

Incidence and management of postoperative pain

Of all 288 patients, 33 (13.5%) reported rectal pain that developed within 1 month after surgery. Six patients (2.1%) reported rectal pain that developed 3 months after surgery (Table 1). The overall opioid consumption was significantly higher in Group P than Group N on postoperative day 5 (Table 3). Fourteen patients (4.9%) had chronic rectal pain that persists more than 3 moths (Table 4). These patients had undergone multiple treatments including anticonvulsants, antidepressants, opioids, and/or rehabilitation exercise (Table 4).
Table 3.

Abdominal pain severity and opioid consumption.

Group N (n = 249)Group P (n = 39)P value
Pain severity (NRS)
 1 h postoperatively5.5 ± 1.05.6 ± 1.10.794
 1 d postoperatively5.9 ± 1.56.1 ± 2.20.484
 3 d postoperatively4.5 ± 1.85.1 ± 2.00.084
 5 d postoperatively3.3 ± 1.23.9 ± 2.00.125
Opioid consumption, µg
 Intraoperative87.0 ± 52.090.2 ± 55.90.737
 1 h postoperatively49.9 ± 26.652.6 ± 31.40.627
 1 d postoperatively80.8 ± 77.1109.2 ± 130.80.194
 3 d postoperatively80.5 ± 82.8115.5 ± 133.50.120
 5 d postoperatively79.0 ± 49.3118.6 ± 79.0*0.004

All data are presented as mean ± SD. Group N: patients without postoperative rectal pain; Group P: patients with postoperative rectal pain; NRS: numeric rating scale. *P < 0.05 compared with Group N.

Table 4.

Rectal pain severity and management in Group P.

Patient No.Postoperative time point
1 h1 d3 d5 d1 mo3 mo6 mo12 mo
130006552
PCAOpioidsAnticonvulsants OpioidsAnticonvulsants Antidepressants OpioidsOpioids AnalgesicsOpioids Analgesics
200405542
PCAOpioidsOpioidsOpioidsAnticonvulsants AnalgesicsAnticonvulsants
300404011
PCAOpioidsRehabilitationObservation
400003042
PCAOpioidsObservationAnticonvulsants OpioidsAnticonvulsants
530000
PCAOpioidsObservation
600060
PCAOpioidsObservation
700600
PCAOpioidsObservation
800080
PCAOpioidsObservation
900400
PCAOpioidsObservation
1000000431
PCAOpioidsObservationOpioidsObservation
110000065
PCAOpioidsObservationOpioids
1200400
PCAOpioidsObservation
1300000033
PCAOpioidsObservationOpioidsObservation
1400000200
PCAOpioidsObservation
1500005000
PCAOpioidsObservation
1600400
PCAOpioidsObservation
1700024422
PCAOpioidsOpioidsRehabilitationObservation
1806000
PCAOpioidsObservation
1900600
PCAOpioidsObservation
2030000031
PCAOpioidsObservationRehabilitationObservation
2100060
PCAOpioidsObservation
2200400
PCAOpioidsObservation
2300005552
PCAOpioidsOpioidsRehabilitation
2400300
PCAOpioidsObservation
2500004553
PCAOpioidsOpioids
2604004143
PCAOpioidsOpioidsAnalgesicsOpioidsRehabilitation
2700004000
PCAOpioidsObservation
2800040
PCAOpioidsObservation
2900050
PCAOpioidsObservation
3000040
PCAOpioidsObservation
3100600
PCAOpioidsObservation
3200600
PCAOpioidsObservation
3304040
PCAOpioidsObservation
3500005650
PCAOpioidsOpioidsObservation
3600000332
PCAOpioidsObservationOpioidsRehabilitation
3770000
PCAOpioidsObservation
3800030
PCAOpioidsObservation
3950000
PCAOpioidsObservation

Pain severity is presented as the numeric rating scale score. PCA: patient-controlled analgesia.

Abdominal pain severity and opioid consumption. All data are presented as mean ± SD. Group N: patients without postoperative rectal pain; Group P: patients with postoperative rectal pain; NRS: numeric rating scale. *P < 0.05 compared with Group N. Rectal pain severity and management in Group P. Pain severity is presented as the numeric rating scale score. PCA: patient-controlled analgesia.

Discussion

Surgical incisions result in tissue damage, subsequent inflammation, and postoperative pain. Although most patients heal without long-term sequelae, several types of surgery such as amputation, thoracotomy, and mastectomy involve obligatory neurologic injury, often leading to a cascade of postinjury sensitization and chronic pain.[11] Rectal tumor resection is a painful surgery. Postsurgical rectal pain may be due to somatic pain from the surgical incision, visceral pain from the intra-abdominal structures, and neuropathic pain from the pelvic plexus.[12] Gilliland et al.[13] found that surgical procedures, including colectomy, were the most frequently cited precipitating factors (19.8%) for the development of intractable rectal pain. Similarly, Atkin et al.[14] found that anal surgery was the most common initiating event and often led to chronic pain and a hypersensitive rectum. However, the pathophysiological mechanisms of postoperative rectal pain have not yet been analyzed. Neural damage during surgery is a well-recognized risk factor for chronic neuropathic pain.[6] In particular, neuropathic cancer pain can be present following cancer-directed therapy.[15] Central processing of pain signals from peripheral acute trauma or inflammation is a proposed factor.[16] Moreover, surgery-induced peripheral neuromodulation in the pelvic cavity and anal canal can influence the spinal cord and cerebral cortex. In the present study, the incidence of rectal pain after laparoscopic rectal cancer surgery was 13.5%. Bouman et al.[17] reported that severe acute postsurgical pain is a predictor of chronic postsurgical pain. Although the perioperative pain scores were not significantly different between the two groups in the present study, Group P consumed a significantly greater amount of opioids. This may be expected because the goal of rescue analgesics is to avoid pain escalation. We also found that an anastomotic margin of <2 cm from the anal verge and a long operation time were positive predictors of postoperative rectal pain. Sensory fibers to the anus are usually present in the anal canal, particularly in the region of the anal valves.[18] Thus, damage to this area may result in much greater pain than damage to other areas because of the increased nociceptive sensitivity in the anal canal. Additionally, prolonged traction and electrocoagulation during surgery can damage the neural plexus of the abdominopelvic cavity. Neuropathic pain induced by intraoperative nerve injury has been proposed as a major cause of chronic postoperative pain.[19] A long operation time can increase the possibility of intraoperative nerve injury, which affects acute and chronic postoperative pain. Visceral afferent and somatic fibers from the distal rectum, anus, and perineum may project to the ganglion impar, which is the most caudal ganglion of the sympathetic trunk. These neuron bundles have been implicated in sympathetically mediated pain in the pelvis, which is characterized by poorly localized pain with a burning quality and sense of urgency.[20] Anorectal postsurgical physiological alterations may also be related to this phenomenon. Disruption of neuromuscular continuity within the rectal wall leads to rectal sensation and compliance abnormalities and can also interfere with the intramural rectoanal reflex.[4,21] This disruption can also cause functional changes such as impaired absorption and impaired secretory function, resulting in rectal discomfort and/or pain. The anal sphincter integrity, rectoanal sensation, rectal compliance, neuronal innervation, stool consistency, and bowel mobility can also be altered after surgery, affecting rectal pain.[22] The presence of diabetes mellitus was a negative predictor of rectal pain in the present study. Although the mechanisms of sensory changes in patients with diabetes mellitus are not fully known, we suspect that loss of intraepidermal nerve fibers and disturbance of peripheral nerve regeneration are associated with altered rectal pain perception.[23] We also considered preoperative CRT, the intraoperative inflammatory response, and postoperative anastomotic leakage as potential inflammatory factors.[24-27] In the present study, Group P underwent more preoperative CRT and experienced more postoperative leakage, although the differences in these factors between the two groups were not significant in our multivariate analysis. Exposure of normal tissue to radiation can generate a sustained and uncontrolled inflammatory response.[24,25] Although many afferent fiber bundles innervating internal organs appear to contain unresponsive afferent fibers, these fibers become activated in the presence of injury, ischemia, and/or inflammation.[12,26] In combination with preoperative primed inflammation, these intraoperative and postoperative inflammatory cascades potentiate nerve sensitivity, leading to postoperative neuropathic pain.[25-27] This study has several limitations. First, we did not assess preoperative anal sphincter function; perioperative bowel symptoms such as frequency, urgency, incontinence, diarrhea, and constipation; the postoperative condition of the anal skin; or postoperative colonoscopy findings. Another limitation is that we did not assess psychosocial factors such as preoperative expectations regarding postoperative pain, pain anxiety, and anxiety sensitivity, all of which can influence postoperative pain. Additionally, this study was retrospective in nature and was therefore potentially biased. Despite these limitations, this is the first attempt to quantify the incidence of rectal pain and identify its related risk factors following laparoscopic rectal cancer surgery. Because a low distal anastomotic margin and long operation time were found to be positive predictors in our study, we recommend preoperative discussions and active perioperative analgesic strategies as preemptive and preventive treatments. Our findings also warrant future well-controlled, prospective randomized trials for reducing pain. In conclusion, rectal pain after laparoscopic rectal cancer surgery was significantly associated with a low anastomotic margin from the anal verge and a long operation time. Our findings suggest that increased attention should be given to the development of rectal pain and that sufficient pain management strategies are needed to effectively prevent postsurgical rectal pain.

Supplementary materials

Jin Young Lee: study design, data collection and analysis, writing and revision of the manuscript. Hee Cheol Kim, Jung Wook Huh: providing criticism of the manuscript. Woo Seog Sim: study design, data collection and analysis, writing and revision of the manuscript. Hyun Young Lim, Eun Kyung Lee, Hui Gyeong Park, Yu Jeong Bang: data collection.
  26 in total

1.  Risk factors and oncologic impact of anastomotic leakage after rectal cancer surgery.

Authors:  Sang Hun Jung; Chang Sik Yu; Pyong Wha Choi; Dae Dong Kim; In Ja Park; Hee Cheol Kim; Jin Cheon Kim
Journal:  Dis Colon Rectum       Date:  2008-04-12       Impact factor: 4.585

Review 2.  A review on functional results of sphincter-saving surgery for rectal cancer: the anterior resection syndrome.

Authors:  Filippo Pucciani
Journal:  Updates Surg       Date:  2013-06-11

3.  Prevalence, characteristics and risk factors of chronic postsurgical pain after laparoscopic colorectal surgery: Retrospective analysis.

Authors:  Jean L Joris; Mathieu J Georges; Kamel Medjahed; Didier Ledoux; Gaëlle Damilot; Caroline C Ramquet; Carla I Coimbra; Laurent P Kohnen; Jean François E Brichant
Journal:  Eur J Anaesthesiol       Date:  2015-10       Impact factor: 4.330

4.  Chronic pain in the pelvic area or lower extremities after rectal cancer treatment and its impact on quality of life: a population-based cross-sectional study.

Authors:  Marie-Louise Feddern; Troels Staehelin Jensen; Søren Laurberg
Journal:  Pain       Date:  2015-09       Impact factor: 6.961

5.  Biofeedback for intractable rectal pain: outcome and predictors of success.

Authors:  R Gilliland; J S Heymen; D F Altomare; D Vickers; S D Wexner
Journal:  Dis Colon Rectum       Date:  1997-02       Impact factor: 4.585

6.  Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis.

Authors:  Zhi Yi Ong; Rachel J Gibson; Joanne M Bowen; Andrea M Stringer; Jocelyn M Darby; Richard M Logan; Ann Sj Yeoh; Dorothy M Keefe
Journal:  Radiat Oncol       Date:  2010-03-16       Impact factor: 3.481

7.  Laparoscopic intersphincteric resection for low rectal cancer.

Authors:  Elena Orsenigo; Saverio Di Palo; Andrea Vignali; Carlo Staudacher
Journal:  Surg Oncol       Date:  2007-11-26       Impact factor: 3.279

Review 8.  Chronic pelvic pain.

Authors:  Andrew Paul Baranowski
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

9.  Neuropathic caner pain: is it linked to the recurrence of cancer?

Authors:  Eun Soo Kim
Journal:  Korean J Pain       Date:  2015-04-01

10.  Chronic persistent post-surgical pain following staging laparotomy for carcinoma of ovary and its relationship to signal transduction genes.

Authors:  Ashok Kumar Saxena; Geetanjali T Chilkoti; Anand K Chopra; Basu Dev Banerjee; Tusha Sharma
Journal:  Korean J Pain       Date:  2016-09-29
View more
  3 in total

1.  Evaluation of the Intraoperative Perfusion Index for Correlation with Acute Postoperative Pain in Patients Undergoing Laparoscopic Colorectal Cancer Surgery.

Authors:  Ji Hye Kwon; Hue Jung Park; Woo Seog Sim; Joo Hyun Park; Kang Ha Jung; Min Seok Oh; Heui Jin Seon; Jin Young Lee
Journal:  J Clin Med       Date:  2019-08-24       Impact factor: 4.241

2.  Analgesic Efficacy of Preemptive Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Colorectal Cancer Surgery.

Authors:  Kwan Young Hong; Duk Kyung Kim; Hue Jung Park; Woo Seog Sim; Won Gook Wi; Woo Yong Lee; Hee Cheol Kim; Jin Young Lee
Journal:  J Clin Med       Date:  2020-05-22       Impact factor: 4.241

3.  Analgesic Efficacy of Nefopam as an Adjuvant in Patient-Controlled Analgesia for Acute Postoperative Pain After Laparoscopic Colorectal Cancer Surgery.

Authors:  Eun Jung Oh; Woo Seog Sim; Won Gook Wi; Jeayoun Kim; Woo Jin Kim; Jin Young Lee
Journal:  J Clin Med       Date:  2021-01-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.